| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
|
Xu, Stanley
|
|
|
40 |
23 |
p. 3150-3158
|
article
|
| 2 |
Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines
|
Beyer, Walter E.P.
|
|
|
40 |
23 |
p. 3098-3102
|
article
|
| 3 |
Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance
|
Markovitz, Netana H.
|
|
|
40 |
23 |
p. 3085-3086
|
article
|
| 4 |
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?
|
Krupp, K.
|
|
|
40 |
23 |
p. 3087-3088
|
article
|
| 5 |
Corrigendum to “Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines” [Vaccine 39(18) (2021) 2506–2516]
|
Stalpers, Coen A.L.
|
|
|
40 |
23 |
p. 3272-3273
|
article
|
| 6 |
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
|
Li, Lei
|
|
|
40 |
23 |
p. 3182-3192
|
article
|
| 7 |
COVID-19 vaccinations in Bhutan – Mix-and-Match to Boosters: An experience
|
Tamang, Saran Tenzin
|
|
|
40 |
23 |
p. 3089-3092
|
article
|
| 8 |
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study
|
Singh, Brajendra K.
|
|
|
40 |
23 |
p. 3165-3173
|
article
|
| 9 |
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers
|
Saade, Anastasia
|
|
|
40 |
23 |
p. 3159-3164
|
article
|
| 10 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
23 |
p. IFC
|
article
|
| 11 |
Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders
|
Beulens, Christian
|
|
|
40 |
23 |
p. 3210-3215
|
article
|
| 12 |
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials
|
Zhu, Feng-Cai
|
|
|
40 |
23 |
p. 3216-3227
|
article
|
| 13 |
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis
|
Streckenbach, Barbara
|
|
|
40 |
23 |
p. 3236-3243
|
article
|
| 14 |
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study
|
Lv, Huakun
|
|
|
40 |
23 |
p. 3263-3271
|
article
|
| 15 |
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
|
Wanlapakorn, Nasamon
|
|
|
40 |
23 |
p. 3203-3209
|
article
|
| 16 |
Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination
|
Chrissian, Ara A.
|
|
|
40 |
23 |
p. 3174-3181
|
article
|
| 17 |
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan
|
Yan, Yan
|
|
|
40 |
23 |
p. 3103-3108
|
article
|
| 18 |
Parental and provider vaccine hesitancy and non-timely childhood vaccination in Switzerland
|
Jafflin, Kristen
|
|
|
40 |
23 |
p. 3193-3202
|
article
|
| 19 |
Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019
|
Seppälä, Elina
|
|
|
40 |
23 |
p. 3142-3149
|
article
|
| 20 |
Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) study
|
Osman, Selma
|
|
|
40 |
23 |
p. 3228-3235
|
article
|
| 21 |
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder
|
Hamid, Fatima A.
|
|
|
40 |
23 |
p. 3244-3252
|
article
|
| 22 |
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial
|
Ortiz, Justin R.
|
|
|
40 |
23 |
p. 3253-3262
|
article
|
| 23 |
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
|
Antonopoulou, Tania
|
|
|
40 |
23 |
p. 3093-3095
|
article
|
| 24 |
Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysis
|
Bianchi, Francesco Paolo
|
|
|
40 |
23 |
p. 3127-3141
|
article
|
| 25 |
Strategies to improve vaccination rates in people who are homeless: A systematic review
|
McCosker, Laura K.
|
|
|
40 |
23 |
p. 3109-3126
|
article
|
| 26 |
War, pandemic and vaccination – Upcoming health problems by the refugee wave in Europe?
|
Perciaccante, Antonio
|
|
|
40 |
23 |
p. 3096-3097
|
article
|
Journal description